For those who are fretting over efficacy not being
Post# of 144499
![](/assets/46931549/no_avatar_available_thumb.jpg)
Quote:
COVID-19 Phase 2 topline report to be submitted for consideration of emergency approval of leronlimab for patients with mild-to-moderate symptoms to U.K. and other countries following submission to the U.S. FDA next week
![Like This Post](/images/thumb-up.png)
![Dislike This Post](/images/thumb-down.png)